PATRICIA WHITT: Open Payments
NPI 1104064294 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 31 payments from 12 companies in 2025. Trend: 2023 $350 · 2024 $394 · 2025 $787
Food & beverage: $687Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $206 |
| BeOne Medicines USA, Inc. | 1 | $135 |
| Daiichi Sankyo Inc. | 10 | $135 |
| Legend Biotech USA Inc. | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 1 | $76 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Celgene Corporation | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
Products named: VENCLEXTA, BRUKINSA, INJECTAFER, CARVYKTI, CALQUENCE, EPKINLY, Vanflyta, PYRUKYND.
Industry payments across OK — which companies pay providers there.
